What does “nanotechnology” refer to? The National Nanotechnology Initiative defines nanotechnology as the understanding and control of matter at dimensions between approximately 1 and 100 nm, where unique phenomena enable novel applications.
Read the full article at http://circres.ahajournals.org/content/109/3/250.long
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is awarding $65 million to renew its Programs for Nanotechnology Research to help researchers develop tools based on materials designed at the molecular level to detect and deliver treatments for heart, lung, and blood diseases.
Read the full story at http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2736
An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools that use nanotechnology to treat heart and lung diseases.
Read the full story at http://news.wustl.edu/news/Pages/21238.aspx
Contract will allow Mount Sinai to develop multidisciplinary research Centers with the goal of developing nanotechnology tools for heart, lung and blood diseases.
The award will support the interdisciplinary Center for Translational Cardiovascular Nanomedicine as the second phase of the Program of Excellence in Nanotechnology.
Read the full story at http://gtresearchnews.gatech.edu/cardiovascular-nanomedicine-center/